NCT06469788 · University of Alabama at Birmingham
Testimonials and Navigation in Rheumatology
(TANGO)
What this study is about
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
View original scientific description
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Interventions
BEHAVIORAL
Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
Participants will watch video focused on the importance of receipt of updated COVID-19 vaccination in patients with AIRD
BEHAVIORAL
Video on the importance of good oral health for patients with AIRD
Participants will watch video on the importance of good oral health in AIRD patients.
BEHAVIORAL
Brochure on COVID-19 vaccination in AIRD patients
Participants
BEHAVIORAL
Patient Navigation
Participants will receive phone calls from patient navigators to provide support and information for receipt of updated COVID-19 vaccination in patients with AIRD
BEHAVIORAL
Brochure on the importance of good oral health in AIRD patients
Participants will receive a brochure on the importance of good oral health in AIRD patients.
Primary outcome measures
Receipt of updated COVID-19 vaccination.
Time frame: 3 months
We will measure rates of receipt of updated COVID-19 vaccination.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Adults (18+ years) with known AIRD
- Black race and/or Latinx ethnicity
- Individuals who have not obtained the updated COVID-19 vaccine series (self-report)
Exclusion criteria
- -Lack of access to phone
Where
- Birmingham, Alabama
- Boston, Massachusetts
- Worcester, Massachusetts
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 6, 2026 · Source of record for eligibility and locations